West Pharmaceutical Services SG&A Expenses 2010-2024 | WST

West Pharmaceutical Services sg&a expenses for the twelve months ending June 30, 2024 were $0.349B, a 6.83% increase year-over-year.

  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
  • West Pharmaceutical Services annual sg&a expenses for 2021 were $0.363B, a 20.13% increase from 2020.

West Pharmaceutical Services SG&A Expenses 2010-2024 | WST

  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
  • West Pharmaceutical Services annual sg&a expenses for 2021 were $0.363B, a 20.13% increase from 2020.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$66.8B
McKesson (MCK)$66.6B
Cardinal Health (CAH)$26.9B
Cooper (COO)$21.9B
Labcorp (LH)$19.1B
Align Technology (ALGN)$18.9B
Henry Schein (HSIC)$9B
Merit Medical Systems (MMSI)$5.7B
DENTSPLY SIRONA (XRAY)$5.4B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$125M
Pro-Dex (PDEX)$83M